Detalhe da pesquisa
1.
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.
J Natl Cancer Inst
; 111(8): 867-871, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30888406